Affiliation:
1. I.M. Schenov First Moscow State Medical University
Abstract
We present the analytical review of non-cardial effects of statins used in gastroenterology with the data illustrating their high antibacterial activity as exemplified by combined therapy of conditions associated with Helicobacter pylori infection. Special emphasis is laid on anti-inflammatory and oncoprotective mechanisms of statin action that are successfully made use offor the treatment of liver, pancreas, gallbladder, and biliary system diseases. Prophylactic aspects of statin application to overcome an addiction to fast food are discussed.
Publisher
Medical Informational Agency Publishers
Reference52 articles.
1. Drapkina O.M., Avilova A.G. Statins and nonalcoholic fatty liver disease. Ateroskleroz i dislipidemiya. 2014; 1: 31—5. (in Russian)
2. Lewis J.H. Prescribing a statin to a cirrhotic patient to reduce hepatic decompensation and improve survival: impossible you say? Dig. Dis. Sci. 2014; 59 (8): 1684-7.
3. Lewis J.H., Mortensen M.E., Zweig S, Fusco M.J., Medoff J.R., Belder R. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Hepatology. 2007; 46 (5): 1453-63.
4. Patrick A.R., Shrank W.H., Glynn R.J., Solomon D.H., Dormuth C.R., Avorn J. et al. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value Health. 2011; 14: 513-20.
5. Demierre M.F., Higgins P.D., Gruber S.B., Hawk E., Lippman S.M. Statins and cancer prevention. Nat. Rev. Cancer. 2005; 5: 930-42.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献